These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36876497)

  • 1. Predictors of target lesion revascularisation after drug-eluting stent implantation for calcified nodules: an optical coherence tomography study.
    Hamana T; Kawamori H; Toba T; Kakizaki S; Nakamura K; Fujimoto D; Sasaki S; Fujii H; Osumi Y; Fujioka T; Nishimori M; Kozuki A; Shite J; Iwasaki M; Takaya T; Hirata KI; Otake H
    EuroIntervention; 2023 Jun; 19(2):e123-e133. PubMed ID: 36876497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical characteristics and prognosis of lesions with in-stent eccentric tissue proliferation and strong signal attenuation detected by optical coherence tomography.
    Suzuki N; Kozuma K; Kyono H; Nakaya H; Nishide S; Mitsui M; Nara Y; Kawashima H; Nomura T; Yamamoto H; Sasajima Y; Kondo F; Isshiki T
    Cardiovasc Interv Ther; 2016 Jul; 31(3):210-7. PubMed ID: 26608163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Calcified Plaque Morphology After Drug Eluting Stent Implantation　- An Optical Coherence Tomography Study.
    Iwai S; Watanabe M; Okamura A; Kyodo A; Nogi K; Kamon D; Hashimoto Y; Ueda T; Soeda T; Okura H; Saito Y
    Circ J; 2021 Oct; 85(11):2019-2028. PubMed ID: 34039823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, predictors, and outcomes of in-stent restenosis with calcified nodules.
    Tada T; Miura K; Ikuta A; Ohya M; Shimada T; Osakada K; Takamatsu M; Taguchi Y; Kubo S; Tanaka H; Fuku Y; Kadota K
    EuroIntervention; 2022 Mar; 17(16):1352-1361. PubMed ID: 34483090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical coherence tomography-derived predictors of stent expansion in calcified lesions.
    Ziedses des Plantes AC; Scoccia A; Neleman T; Groenland FTW; van Zandvoort LJC; Ligthart JMR; Witberg KT; Liu S; Boersma E; Nuis RJ; den Dekker WK; Wilschut J; Diletti R; Zijlstra F; Van Mieghem NM; Daemen J
    Catheter Cardiovasc Interv; 2023 Jul; 102(1):25-35. PubMed ID: 37210611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular Response After Everolimus-Eluting Stent in Acute Myocardial Infarction Caused by Calcified Nodule.
    Ino Y; Takahata M; Kubo T; Khalifa AKM; Satogami K; Terada K; Ozaki Y; Katayama Y; Taruya A; Ota S; Wada T; Tanimoto T; Shiono Y; Kashiwagi M; Kuroi A; Tanaka A
    Circ J; 2022 Aug; 86(9):1388-1396. PubMed ID: 35545551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical impact of OCT-derived suboptimal stent implantation parameters and definitions.
    Romagnoli E; Burzotta F; Vergallo R; Gatto L; Biondi-Zoccai G; Ramazzotti V; Biccirè F; Budassi S; Trani C; Ali Z; Stone GW; Prati F
    Eur Heart J Cardiovasc Imaging; 2023 Dec; 25(1):48-57. PubMed ID: 37463223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial.
    Ali ZA; Maehara A; Généreux P; Shlofmitz RA; Fabbiocchi F; Nazif TM; Guagliumi G; Meraj PM; Alfonso F; Samady H; Akasaka T; Carlson EB; Leesar MA; Matsumura M; Ozan MO; Mintz GS; Ben-Yehuda O; Stone GW;
    Lancet; 2016 Nov; 388(10060):2618-2628. PubMed ID: 27806900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
    Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
    Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment.
    Mitsui K; Lee T; Miyazaki R; Hara N; Nagamine S; Nakamura T; Terui M; Okata S; Nagase M; Nitta G; Watanabe K; Kaneko M; Nagata Y; Nozato T; Ashikaga T
    Catheter Cardiovasc Interv; 2023 Jul; 102(1):11-17. PubMed ID: 37210618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Implications of Poststent Optical Coherence Tomographic Findings: Severe Malapposition and Cardiac Events.
    Kim BG; Kachel M; Kim JS; Guagliumi G; Kim C; Kim IS; Lee YJ; Lee OH; Byun YS; Kim BO; Milewski K; Lee SJ; Hong SJ; Ahn CM; Shin DH; Kim BK; Ko YG; Choi D; Jang Y
    JACC Cardiovasc Imaging; 2022 Jan; 15(1):126-137. PubMed ID: 34023255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
    Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical coherence tomography assessment of incidence, morphological characteristics, and spontaneous healing course of edge dissections following percutaneous coronary intervention with stent implantation in patients with non-ST segment elevation myocardial infarction.
    Antonsen L; Thayssen P; Hansen HS; Junker A; Veien KT; Hansen KN; Hougaard M; Jensen LO
    Int J Cardiol; 2016 Nov; 223():466-474. PubMed ID: 27544607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention).
    Maehara A; Ben-Yehuda O; Ali Z; Wijns W; Bezerra HG; Shite J; Généreux P; Nichols M; Jenkins P; Witzenbichler B; Mintz GS; Stone GW
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1704-14. PubMed ID: 26585621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of optical coherence tomography findings after drug-coated balloon treatment for patients with acute coronary syndromes.
    Yamamoto T; Kawamori H; Toba T; Kakizaki S; Nakamura K; Fujimoto D; Sasaki S; Fujii H; Hamana T; Osumi Y; Iwane S; Naniwa S; Sakamoto Y; Matsuhama K; Fukuishi Y; Kozuki A; Shite J; Iwasaki M; Ishida A; Hirata KI; Otake H
    Int J Cardiol; 2023 Sep; 387():131149. PubMed ID: 37423566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical coherence tomography factors for adverse events in patients with severe coronary calcification.
    Nagata T; Minami Y; Katsura A; Asakura K; Katamine M; Muramatsu Y; Fujiyoshi K; Kinoshita D; Ako J
    Int J Cardiol; 2023 Apr; 376():28-34. PubMed ID: 36804764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of lesion angle on optical coherence tomography findings and clinical outcomes after drug-eluting stent implantation in curved vessels.
    Nakamura S; Kimura S; Nakagama S; Misawa T; Mizusawa M; Hayasaka K; Yamakami Y; Kojima K; Sagawa Y; Hishikari K; Hikita H; Takahashi A; Hirao K
    Int J Cardiovasc Imaging; 2019 Dec; 35(12):2147-2155. PubMed ID: 31359232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower on-treatment platelet reactivity during everolimus-eluting stent implantation contributes to the resolution of post-procedural intra-stent thrombus: serial OCT observation in the PRASFIT-Elective study.
    Konishi A; Iwasaki M; Shinke T; Otake H; Nakagawa M; Hariki H; Osue T; Inoue T; Taniguchi Y; Nishio R; Kinutani H; Hiranuma N; Kuroda M; Hirata KI; Saito S; Nakamura M; Shite J; Akasaka T
    Heart Vessels; 2018 Dec; 33(12):1423-1433. PubMed ID: 29967954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.